Every year, hundreds of millions of patients worldwide undergo surgical procedures  and a large proportion face post-operative complications. Among these, infections remain the most common yet often go unnoticed until symptoms surface, sometimes days after surgery. This delay can lead to longer hospital stays, increased morbidity, and higher costs. 

To tackle this, Dutch-based Healthplus.ai developed PERISCOPE  an AI-powered clinical decision-support tool that ingests data from electronic health records (EHRs) and runs predictive modeling to estimate each patient’s risk of post-surgery infection. The system categorizes patients into risk tiers (low, medium, high), allowing medical teams to prioritise monitoring, interventions, or preventive measures before infection takes hold. 

In its latest funding round  raising €2.3 million  the company plans to use the funds to scale globally. The money will help Healthplus.ai gain regulatory approvals (for instance, FDA clearance for U.S. hospitals), build deeper integrations with leading EHR platforms (like Epic, Cerner, ChipSoft), and further refine and expand AI models to predict not only infections but a broader array of perioperative complications. 

According to Healthplus.ai’s CEO (and co-founder) Dr. Bart Geerts, the goal goes beyond technology: “We aim to bring clinically validated, regulatory-approved AI into everyday hospital practice,” enabling surgeons, nurses and hospital IT teams to use data-driven insights to proactively safeguard patient health.